Attorney General Miyares Launches Civil Rights Investigation

Attorney General Jason Miyares today announced that his Office of Civil Rights will be investigating Fairfax County

Public Schools and the administration of Thomas Jefferson High School for Science and Technology (“TJHSST”) for

unlawful discrimination in violation of the Virginia Human Rights Act (“VHRA”).

The investigation will examine if the administration’s decision to withhold National Merit Scholarship honors from

students and the school’s new admissions policies violate the VHRA.

“No student should be treated differently because of their race. Students at Thomas Jefferson High School for Science

and Technology are amongst the brightest in the nation, yet some have been punished in the name of ‘equity.’ Racism

and race-based government decision making in any form is wrong and unlawful under Virginia’s Human Rights Act,”

said Attorney General Miyares. “The controversial admissions policies at TJHSST, which have significantly decreased

the amount of Asian American students enrolled in recent years, is another example of students being treated

differently because of their ethnicity. My Office of Civil Rights will investigate any potential violations of the law and

vindicate the civil rights of these students and their families.”

Read the letter here.

 

 

For more news from across the Shenandoah Valley, click here.

Walmart reaches opioid settlement with VA and nation

Attorney General Jason Miyares announced Friday that his office has reached a settlement with Walmart.

The settlement came after allegations that the company contributed to the opioid addiction crisis by failing to appropriately oversee the dispensing of opioids at its stores.

The settlement will provide more than $3 billion nationally and approximately $60 million to Virginia.

It will also require significant improvements on how Walmart’s pharmacies handle opioids.

State attorneys general on the executive committee, attorneys representing local governments, and Walmart have agreed to this settlement, and it is now being sent to other states for review and approval.

“Companies who facilitated the dispensing of opioids contributed to the opioid epidemic that has devastated millions of lives. This significant settlement will help us fight back against the epidemic and provide abatement and rehabilitation resources to suffering Virginians,” said Attorney General Jason Miyares.

The settlement will include:

• $3.1 billion to be divided by states that sign on, local governments, and tribes, for abatement and remediation of the opioid crisis, including treatment and recovery services to people struggling with opioid use disorder.

• Broad, court-ordered requirements, including robust oversight to prevent fraudulent prescriptions and flag suspicious prescriptions.

The parties are optimistic that the settlement will gain support of the required 43 states by the end of 2022.

That will allow local governments to join the deal during the first quarter of 2023.

Further details about the distribution of the money are forthcoming.

Last month, states confirmed that promising negotiations were also underway with Walgreens and CVS.

The parties continue their efforts to achieve those agreements.

Read the agreement and term sheet here.

For more news from across the Shenandoah Valley, click here.

Va.’s Attorney General Miyares announces Opioid settlement

Virginia’s Attorney General Jason Miyares announced that the Commonwealth has received its first initial payment from an opioid manufacturer.

Janssen Pharmaceuticals is a subsidiary of Johnson and Johnson and they have made a payment of $67.4 million which includes approximately $11.3 million for the state, $16.3 million for Virginia localities and $39.8 million for the Opioid Abatement Authority.

Miyares stated that this helps the Commonwealth fight back against the opioid epidemic as well as reduce, prevent and treat addiction.

The settlement also requires Johnson and Johnson to stop selling opioids in the United States.

The settlement also prevents Johnson and Johnson from promoting opioids or funding third parties that promote opioids.

Johnson and Johnson will also be prohibited from lobbying on legislation, regulations or activities related to opioids.

To date Virginia will receive approximately $532.9 million from opioid distributor settlements collectively.

For more news from across the Shenandoah Valley, click here.